{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:00:54Z","timestamp":1791176454179,"version":"4.1.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1124\/dmd.112.046375","type":"journal-article","created":{"date-parts":[[2012,7,22]],"date-time":"2012-07-22T00:14:22Z","timestamp":1342916062000},"page":"2021-2025","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Glycemic Control and Chronic Dosing of Rhesus Monkeys with a Fusion Protein of Iduronidase and a Monoclonal Antibody Against the Human Insulin Receptor"],"prefix":"10.1016","volume":"40","author":[{"given":"Ruben J.","family":"Boado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric Ka-Wai","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff Zhiqiang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William M.","family":"Pardridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.112.046375_bib1","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.2337\/db11-1578","article-title":"A fully human, allosteric monoclonal antibody that activates the insulin receptor and improves glycemic control","volume":"61","author":"Bhaskar","year":"2012","journal-title":"Diabetes"},{"key":"10.1124\/dmd.112.046375_bib2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jbiotec.2009.08.019","article-title":"AGT-181: expression in CHO cells and pharmacokinetics, safety, and plasma iduronidase enzyme activity in Rhesus monkeys","volume":"144","author":"Boado","year":"2009","journal-title":"J Biotechnol"},{"key":"10.1124\/dmd.112.046375_bib3","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1021\/mp200136x","article-title":"Reversal of lysosomal storage in brain of adult MPS-I mice with intravenous Trojan horse-iduronidase fusion protein","volume":"8","author":"Boado","year":"2011","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.112.046375_bib4","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/bit.21602","article-title":"Genetic engineering of a lysosomal enzyme fusion protein for targeted delivery across the human blood-brain barrier","volume":"99","author":"Boado","year":"2008","journal-title":"Biotechnol Bioeng"},{"key":"10.1124\/dmd.112.046375_bib5","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S1474-4422(04)00938-X","article-title":"Enzyme-replacement therapy for metabolic storage disorders","volume":"3","author":"Brady","year":"2004","journal-title":"Lancet Neurol"},{"key":"10.1124\/dmd.112.046375_bib6","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/0006-291X(89)91056-5","article-title":"Monoclonal antibodies to the human insulin receptor mimic a spectrum of biological effects in transfected 3T3\/HIR fibroblasts without activating receptor kinase","volume":"165","author":"Brunetti","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/dmd.112.046375_bib7","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0020-7519(93)90160-Z","article-title":"Metabolic disturbances in Plasmodium coatneyi-infected rhesus monkeys","volume":"23","author":"Davis","year":"1993","journal-title":"Int J Parasitol"},{"key":"10.1124\/dmd.112.046375_bib8","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.2337\/diabetes.48.10.1915","article-title":"No effect of insulin on glucose blood-brain barrier transport and cerebral metabolism in humans","volume":"48","author":"Hasselbalch","year":"1999","journal-title":"Diabetes"},{"key":"10.1124\/dmd.112.046375_bib9","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1210\/jc.2010-0167","article-title":"Treatment of type B insulin resistance: a novel approach to reduce insulin receptor autoantibodies","volume":"95","author":"Malek","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1124\/dmd.112.046375_bib10","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1651-2227.2005.tb02114.x","article-title":"Enzyme replacement therapy in mucopolysaccharidosis type I","volume":"94","author":"Miebach","year":"2005","journal-title":"Acta Paediatr Suppl"},{"key":"10.1124\/dmd.112.046375_bib11","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1007\/s11095-009-9939-6","article-title":"Pharmacokinetics and safety in rhesus monkeys of a monoclonal antibody-GDNF fusion protein for targeted blood-brain barrier delivery","volume":"26","author":"Pardridge","year":"2009","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.112.046375_bib12","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1111\/j.1471-4159.1985.tb07167.x","article-title":"Human blood-brain barrier insulin receptor","volume":"44","author":"Pardridge","year":"1985","journal-title":"J Neurochem"},{"key":"10.1124\/dmd.112.046375_bib13","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1023\/A:1016244500596","article-title":"Human insulin receptor monoclonal antibody undergoes high affinity binding to human brain capillaries in vitro and rapid transcytosis through the blood-brain barrier in vivo in the primate","volume":"12","author":"Pardridge","year":"1995","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.112.046375_bib14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0002-9343(81)90108-X","article-title":"Cerebrospinal fluid to serum glucose ratios in diabetes mellitus and bacterial meningitis","volume":"71","author":"Powers","year":"1981","journal-title":"Am J Med"},{"key":"10.1124\/dmd.112.046375_bib15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1023\/A:1010379320378","article-title":"Enzyme replacement therapy in mucopolysaccharidosis type I: progress and emerging difficulties","volume":"24","author":"Wraith","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"10.1124\/dmd.112.046375_bib16","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1124\/dmd.111.042903","article-title":"Brain-penetrating IgG-iduronate 2-sulfatase fusion protein for the mouse","volume":"40","author":"Zhou","year":"2012","journal-title":"Drug Metab Dispos"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624061488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624061488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.112.046375","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T18:46:17Z","timestamp":1739904377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624061488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":16,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0090955624061488"],"URL":"https:\/\/doi.org\/10.1124\/dmd.112.046375","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycemic Control and Chronic Dosing of Rhesus Monkeys with a Fusion Protein of Iduronidase and a Monoclonal Antibody Against the Human Insulin Receptor","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.112.046375","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2012 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}